Glaucoma and Depression: The Silent Connection
Glaucoma can affect your mental health as much as your vision. Learn why anxiety and depression are common and what you can do.
glaucoma mental health
When Vision Loss Becomes Emotional Burden
You’ve just been told you have glaucoma. The doctor explains that your eye pressure is elevated and that you need to start treatment. But what they might not mention is something equally important: the emotional weight that often accompanies this diagnosis. For many people with glaucoma, the fear of losing sight can be just as challenging as managing the condition itself.
The connection between glaucoma and mental health is deeper than most patients realize. Vision loss from glaucoma doesn’t just affect how you see the world—it can profoundly impact your psychological well-being, creating a cycle of anxiety and depression that needs attention alongside your medical treatment.
How Common Is Depression With Glaucoma?
The numbers are striking. Research shows that approximately one-third of patients with vision impairment and eye diseases experience mild depressive symptoms. More concerning, between 10.7% to 45.2% of study participants report moderate to severe depressive symptoms.
According to Leon Herndon Jr, MD, division chief of glaucoma and professor of ophthalmology at Duke University, his real-world clinical experience aligns with these findings. Among his patients—many of whom have advanced disease—he observes that 25% to 33% experience some form of anxiety or depression.
What makes this particularly troubling is that patients often experience more anxiety than clinical depression. Many people fear blindness more intensely than they fear a cancer diagnosis or paralysis, yet they may feel reluctant to voice these fears to their ophthalmologist.
The Fear That Goes Unspoken
Dr. Herndon notes that anxiety often stems from uncertainty about the future. Patients worry about whether their vision loss will inevitably lead to blindness, but they’re often afraid to ask this question directly. As a result, their anxiety can spiral without professional acknowledgment or reassurance.
Recognizing this fear requires more than standard eye exam conversations. Physicians can pick up on patient anxiety by observing non-verbal cues—the tension in a room, the body language of family members present during appointments, and the unspoken worry visible in a patient’s eyes.
To address this gap, Dr. Herndon uses a direct approach: he has candid conversations with patients about their disease stage and prognosis. He places patients on a scale from 1 to 10, ranging from early-stage disease to blindness from glaucoma. This clarity often helps patients with disproportionate anxiety understand their actual situation, which can ease their concerns considerably. Conversely, it can also prompt patients who haven’t been taking their diagnosis seriously to reconsider their treatment compliance.
Anxiety and Depression May Accelerate Glaucoma Progression
Recent research suggests an even more complex relationship between mental health and glaucoma. A Korean study published in Scientific Reports evaluated whether anxiety and depression actually cause glaucoma to worsen, not just as a psychological consequence of diagnosis.
The researchers conducted a retrospective case-control study of 251 eyes with open-angle glaucoma followed for at least 2 years. They classified patients into four groups based on their scores on the Beck Anxiety Inventory and Beck Depression Inventory-II.
The findings were notable: patients with higher anxiety scores showed faster rates of retinal nerve fiber layer (RNFL) thinning, higher intraocular pressure (IOP), and more frequent disc hemorrhages. Anxiety scores were significantly correlated with both the rate of RNFL thinning and IOP fluctuations.
Patients with higher depression scores showed worse visual field mean deviation and elevated heart rate variability. The researchers propose that anxiety may increase glaucoma progression through effects on IOP regulation and blood flow to the optic nerve—suggesting that anxiety and depression may be both a consequence of and a risk factor for glaucoma progression.
Does Anxiety Increase Glaucoma Risk?
Another group of researchers at Duke University tested whether this relationship exists even in glaucoma suspects—people at risk but not yet diagnosed. Samuel Berchuck, PhD, an assistant professor of biostatistics and bioinformatics at Duke University, and colleagues retrospectively assessed anxiety and depression’s impact on glaucoma diagnosis risk in 3,259 glaucoma suspects followed over an average of 3.6 years.
During the follow-up period, 28% of participants were diagnosed with glaucoma. At baseline, 32% had anxiety diagnoses and 33% had depression diagnoses. Among those with anxiety, patients experienced larger IOP fluctuations during follow-up. These findings suggest that screening patients for psychiatric disorders may help identify those at higher risk of developing glaucoma.
The Sleep and Vision Loss Connection
The impact of glaucoma on mental health extends beyond depression and anxiety. A German study examined depression, anxiety, and sleep disturbances in patients with severe visual field defects (VFD) compared to those with no or mild VFD.
The results were striking: patients with severe VFD had significantly higher rates of depression (18.3% versus 2.7%), trait anxiety (28.5% versus 10.8%), and sleep disturbances (75.5% versus 46%). Having severe VFD was associated with a 4 times higher risk of depression, 6 times higher risk of trait anxiety, and a 4 times higher risk of sleep disturbance compared to those with no or mild VFD.
The researchers recommend routine screening for depression, anxiety, and sleep issues in glaucoma patients, particularly those with severe VFD, and suggest that interdisciplinary approaches incorporating psychiatric assessment may be beneficial.
Understanding Charles Bonnet Syndrome
One condition that often goes unrecognized by primary care physicians is Charles Bonnet syndrome (CBS), which causes visual hallucinations in people with severe vision loss from conditions like advanced glaucoma. Patients might see patterns, people, animals, flowers, or buildings that aren’t actually present.
The exact cause remains unknown, but researchers believe these hallucinations result from deafferentation—a loss of signals from the eye to the brain. When these inhibitory signals are absent, increased spontaneous nerve activity in the brain is perceived as hallucinations.
The problem arises when primary care physicians aren’t aware of CBS and misinterpret hallucinations as psychiatric symptoms, potentially prescribing antipsychotic medications unnecessarily. Education about CBS and its benign nature can prevent unnecessary medication while relieving patient anxiety. In Dr. Herndon’s practice, patients have reported fewer hallucinations simply after learning the syndrome is normal and harmless.
Building a Comprehensive Support System
Managing the mental health aspects of glaucoma requires more than just eye care. Dr. Herndon emphasizes the importance of open communication between ophthalmologists and patients’ primary care physicians, as well as involving optometrists in the care plan.
Access to additional resources makes a significant difference. Social workers and visual rehabilitation services can provide crucial support. Duke University, for example, operates a clinic offering occupational therapy to help patients maximize their remaining vision and adjust to vision changes.
Beyond clinical intervention, hope matters. Dr. Herndon stresses that giving patients realistic optimism about their ability to retain vision with appropriate care can prevent anxiety and depression from spiraling out of control.
When to See Your Eye Doctor
If you’ve been diagnosed with glaucoma and notice persistent anxiety, depression, or sleep problems, discuss these with your ophthalmologist. Ask direct questions about your disease stage and prognosis. Request referrals to mental health professionals, social workers, or visual rehabilitation services if available. If you experience visual hallucinations, inform your eye care team—it may be Charles Bonnet syndrome rather than a psychiatric condition requiring different treatment.
